United States· US:62072-008_7cc4bb96-ecf8-42c2-b4d2-01b9ceef3c09

Fludeoxyglucose

A medicinal product containing fludeoxyglucose f-18, registered in United States by Kreitchman PET Center.

US label

Checked against FDA National Drug Code directory (United States) on

Informational only — not a medical device.

SOURCE REGISTER · USFDA National Drug Code directory (Unite…normalisedFludeoxyglucoseATC—REGISTER NO.US:62072-008_7cc4bb96…PACKS LISTED2CHECKEDSeptember 27, 2026

The record

At a glance

FDA National Drug Code directory (United States)
Active substance
FLUDEOXYGLUCOSE F-18
Manufacturer
Kreitchman PET Center
Country
United States (US)
ATC code
—
Reimbursed
Not published by this register
Source register
FDA National Drug Code directory (United States)
Last checked
September 27, 2026

Packs & prices · 2

  • ndc11
    62072-008-30
  • ndc11
    6207200830
    30 mL in 1 VIAL, MULTI-DOSE (62072-008-30)

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Fludeoxyglucose f-18 in 8 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All fludeoxyglucose f-18 products

Authorised across Europe · EMA

The same active substance is authorised in 29 EEA countries. Names it is sold under:

  • Austria · [18f] Fludeoxyglucose Biont, [18f] Fludeoxyglucose Curium
  • Belgium · (18f) Fludeoxyglucose Curium, Fludeoxyglucose (18f) Rtm
  • Bulgaria · [18f] Фдг Биокосмос, Bulrad 18f-Fdg
  • Cyprus · [18f] Fdg, Fludeoxyglucose (18f) Ge Healthcare
  • Czechia · [18f]fdg-Fr, 2-[18f]-Fdg Radiomedic
  • Germany · [18f]-Fdg-Fzk Zag Zyklotron, [18f]fdg
  • Denmark · Flucore, Fludeoxyglucose (F-18)
  • Estonia · [18f]fdg-Fr Life Radiopharma, Fludeomap
  • Spain · Barnascan, Fludesoxiglucosa (18f) Curium
  • Finland · Fludeomap
  • France · Efdege, Fludesoxyglucose (18f) Curium
  • United Kingdom (Northern Ireland) · Ertracer, Fludeoxyglucose (18f) Alliance Medical Radiopharmacy
  • Greece · [18f] Fdg Βιοκοσμοσ, Fludeoxyglucose (18f) Ge Healthcare
  • Croatia · Efdege, Fdg-Rmc
  • Hungary · Fdg Kedoi, Gluco-Pet
  • Ireland · Ertracer
  • Italy · Efdege, Fluodeossiglucosio (18f ) Curium
  • Lithuania · Fludeomap, Fludeoxyglucose (18f)
  • Luxembourg · (18f) Fludeoxyglucose Curium, [18f]fdg-Fr
  • Latvia · [18f]fdg-Fr, Fludeomap
  • Malta · Fludeoxyglucose (18f) Curium
  • Netherlands · [18f]fdg, 18f-Fdg Hoboken
  • Norway · Fludeomap, Fludeoxyglucose (18f) Ge Healthcare
  • Poland · Fdg Pozyton Centrum Onkologii Im. Prof. Franciszka Łukaszczyka W Bydgoszczy, Fdgtomosil
  • Portugal · Fludeoxiglucose (18f) Curium, Gluscan
  • Romania · Fid-F, Fludeoxiglucoză (18f) Monrol
  • Sweden · Flucorpus, Fludeomap
  • Slovenia · [18f]fludeoksiglukoza Curium, Efdege
  • Slovakia · [18f]fdg-Fr Alliance Medical Rp Berlin Gmbh, 18-Fd-Glukoza

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/c6ee8bea-aaaa-4892-b7b7-4301be1710c9
GET /v1/drugs/c6ee8bea-aaaa-4892-b7b7-4301be1710c9?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "route": "INTRAVENOUS",
  "source": "ndc",
  "strength": "100",
  "substance": "FLUDEOXYGLUCOSE F-18",
  "productndc": "62072-008",
  "dosage_form": "INJECTION",
  "dea_schedule": null,
  "strength_unit": "mCi/mL",
  "application_number": "ANDA203942",
  "marketing_category": "ANDA"
}

See everything about fludeoxyglucose f-18.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.